Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Miele

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Clinical Proteomics|March 13, 2024
Proteomics of prostate cancer serum and plasma using low and high throughput approachesGhaith M Hamza, Rekha Raghunathan, Stephanie Ashenden, et al.
International Journal of Molecular Sciences|June 28, 2023
Affi-BAMS™: A Robust Targeted Proteomics Microarray Platform to Measure Histone Post-Translational ModificationsGhaith M Hamza, Eric Miele, Don M Wojchowski, et al.
NAR Molecular Medicine|April 1, 2026
Integrating transcriptomics and proteomics to assess antisense oligonucleotide safety and efficacy: a time-resolved approachDaniel van Leeuwen, Miriam Cipullo, Eleanor C Williams, et al.
Archives of Toxicology|May 16, 2024
Mechanistic safety assessment via multi-omic characterisation of systemic pathway perturbations following in vivo MAT2A inhibitionValentina Fogal, Filippos Michopoulos, Andrew F Jarnuczak, et al.
ACS Chemical Biology|December 27, 2021
Mechanistic Insights into a CDK9 Inhibitor Via Orthogonal Proteomics MethodsJ Adam Hendricks, Nigel Beaton, Alexey Chernobrovkin, et al.
Nature Communications|March 25, 2026
A dihydrouracil CRBN ligand mitigates IMiD associated safety liabilities in heterobifunctional targeted protein degraderMonica C Rodrigo-Brenni, Jasper C Komen, Ghaith M Hamza, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Clinical Proteomics|March 13, 2024
Proteomics of prostate cancer serum and plasma using low and high throughput approachesGhaith M Hamza, Rekha Raghunathan, Stephanie Ashenden, et al.
International Journal of Molecular Sciences|June 28, 2023
Affi-BAMS™: A Robust Targeted Proteomics Microarray Platform to Measure Histone Post-Translational ModificationsGhaith M Hamza, Eric Miele, Don M Wojchowski, et al.
NAR Molecular Medicine|April 1, 2026
Integrating transcriptomics and proteomics to assess antisense oligonucleotide safety and efficacy: a time-resolved approachDaniel van Leeuwen, Miriam Cipullo, Eleanor C Williams, et al.
Archives of Toxicology|May 16, 2024
Mechanistic safety assessment via multi-omic characterisation of systemic pathway perturbations following in vivo MAT2A inhibitionValentina Fogal, Filippos Michopoulos, Andrew F Jarnuczak, et al.
ACS Chemical Biology|December 27, 2021
Mechanistic Insights into a CDK9 Inhibitor Via Orthogonal Proteomics MethodsJ Adam Hendricks, Nigel Beaton, Alexey Chernobrovkin, et al.
Nature Communications|March 25, 2026
A dihydrouracil CRBN ligand mitigates IMiD associated safety liabilities in heterobifunctional targeted protein degraderMonica C Rodrigo-Brenni, Jasper C Komen, Ghaith M Hamza, et al.
Pageof 1